KFU. Card publication. Deneka A. Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)

KAZAN
FEDERAL UNIVERSITY

- RUS
- 中文
- ES

DENEKA A. MUSASHI 2 (MSI2) EXPRESSION AS AN INDEPENDENT PROGNOSTIC BIOMARKER IN NON-SMALL CELL LUNG CANCER (NSCLC)

Form of presentation

Articles in international journals and collections

Year of publication

2020

��

��

Authors, employees of KFU

Abramova Zinaida Ivanovna, author

Bibliographic description in the original language

Deneka A. Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)/A.Deneka…Y. Topchu, A. Mazitova, Zi. Abramova, V. Yugai, E. M. Frantsiyants, O. Ivanovich Kit, Yanis Boumber// Journal of Clinical Oncology. - 2020.- V 38, Is. 15_suppl e21583-e21583

Annotation

Elevated MSI2 expression in primary NSCLC tumors is associated with poor prognosis and can be used as a novel potential prognostic biomarker in NSCLC patients. Future studies in an extended patient cohort are strongly warranted.

Keywords

Musashi 2, prognostic biomarker, non-small cell lung cancer

The name of the journal

JOURNAL OF CLINICAL ONCOLOGY

URL

https://ascopubs.org/doi/abs/10.1200/JCO.2020.38.15_suppl.e21583?af=R

Please use this ID to quote from or refer to the card

https://repository.kpfu.ru/eng/?p_id=242021&p_lang=2

Full metadata record

Field DC	Value	Language
dc.contributor.author	Abramova Zinaida Ivanovna	ru_RU
dc.date.accessioned	2020-01-01T00:00:00Z	ru_RU
dc.date.available	2020-01-01T00:00:00Z	ru_RU
dc.date.issued	2020	ru_RU
dc.identifier.citation	Deneka A. Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)/A.Deneka…Y. Topchu, A. Mazitova, Zi. Abramova, V. Yugai, E. M. Frantsiyants, O. Ivanovich Kit, Yanis Boumber// Journal of Clinical Oncology. - 2020.- V 38, Is. 15_suppl e21583-e21583	ru_RU
dc.identifier.uri	https://repository.kpfu.ru/eng/?p_id=242021&p_lang=2	ru_RU
dc.description.abstract	JOURNAL OF CLINICAL ONCOLOGY	ru_RU
dc.description.abstract	Elevated MSI2 expression in primary NSCLC tumors is associated with poor prognosis and can be used as a novel potential prognostic biomarker in NSCLC patients. Future studies in an extended patient cohort are strongly warranted.	ru_RU
dc.language.iso	ru	ru_RU
dc.subject	Musashi 2	ru_RU
dc.subject	prognostic biomarker	ru_RU
dc.subject	non-small cell lung cancer	ru_RU
dc.title	Deneka A. Musashi 2 (MSI2) expression as an independent prognostic biomarker in non-small cell lung cancer (NSCLC)	ru_RU
dc.type	Articles in international journals and collections	ru_RU